Business Context and Reporting Period
This Form 8-K is a current report filed by Sonim Technologies, Inc. (not DNA X, Inc.) on September 15, 2021. The filing addresses a material corporate action regarding the company's capital structure.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a corporate governance event.
Material Changes
The primary material change reported is a one-for-ten reverse stock split of the company's common stock.
- Effective Time: 5:00 p.m. Eastern Time on September 15, 2021.
- Mechanism: Every ten (10) shares of issued and outstanding common stock were converted into one (1) share.
- Fractional Shares: No fractional shares were issued; holders entitled to fractions received cash in lieu thereof (rounded down to the nearest cent).
- Trading Details: Trading on a split-adjusted basis began on September 16, 2021, on the Nasdaq Capital Market under the symbol SONM with a new CUSIP number (83548F 200).
- Capital Structure: The par value ($0.001) and the authorized number of shares remained unchanged.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document serves solely to disclose the amendment to the Articles of Incorporation and the execution of the reverse stock split.
Investor Verification Checklist
- Verify the new CUSIP number (83548F 200) for future trading and record-keeping.
- Confirm the adjusted share count in brokerage accounts following the 1-for-10 conversion.
- Check for cash payments received in lieu of fractional shares, noting they are subject to withholding taxes.
- Review the attached Exhibit 3.1 (Certificate of Amendment) for the complete legal text of the amendment.